Specialist in Canine Medicine

(What does this mean?)

Dr Jody Braddock graduated from the University of Sydney and worked in private small animal practice for a number of years before returning to the university for an internship in Small Animal Medicine & Surgery and Postgraduate Diploma of Veterinary Clinical Studies. She continued as a Resident in Small Animal Medicine and completed a Masters degree (Thesis: Investigation of some alternative therapies for management of pituitary-dependent hyperadrenocorticism in the dog) and a Fellowship training program. Jody then worked at the University of Sydney Veterinary Teaching Hospital as a Senior Registrar before taking up a position at the University of Sydney as Lecturer in Veterinary Medicine. She attained Fellowship of the Australian College of Veterinary Scientists in 2004 and is a registered specialist in Canine Medicine. Jody has been in private referral practice in Sydney for the last 18 years and is a founding partner of a new purpose-built multidisciplinary specialist small animal hospital – SASH Alexandria. Jody also works as a consultant to a leading diagnostic laboratory service, providing veterinarians of the east coast states and Tasmania with interpretation of laboratory results and clinical support, and continues collaborative research in a number of areas – including long-term effects and outcomes of trilostane treatment and other medical aspects of treated and untreated hyperadrenocorticism in dogs. Her clinical interests encompass all facets of canine and feline medicine with particular interest and expertise in endocrine disease, pharmacology and clinical pathology, and a passion for management and complex care of ageing companion animals.

Publications

• SF Foster, JM Morton, LM Fleeman JA Braddock,KFA Langner^. Safety and effectiveness of tightly controlled hypercortisolism in dogs treated with trilostane in general practice.
• [Abstract] Society of Comparative Endocrinology.  Philadelphia 2023.
• S. Foster; L.M. Fleeman; K.F.A. Langner; J.A. Braddock. Efficacy and Safety of Tightly Controlled Hyperadrenocorticism in Dogs Treated with Trilostane in General Practice. [Abstract] ECVIM-CA 2020.
• Dengate AL, Morel-Kopp MC, Beatty JA, Barrs V, Braddock JA, Churcher RK, Wilson BJ, Christopher M Ward. Differentiation between dogs with thrombosis and normal dogs using the overall hemostasis potential assay. J Vet Emerg Crit Care 2016;3:446-452
• Dengate AL, Culvenor JA, K Graham, Braddock JA, Churcher RK. Bronchial stent placement in a dog with bronchomalacia and left atrial enlargement. J Small Anim Pract 2014;55:225-8
• Dengate AL, Morel-Kopp MC, Beatty JA,  Barrs V, Braddock JA, Churcher RK, Wilson BJ, Christopher M Ward. Evaluation and modification of the overall hemostasis potential assay for use with canine plasma. Am J Vet Res 2013;74:1493-8
• A. Dengate; M.C. Morel-Kopp; J. Braddock; R. Churcher; J. Beatty; V. Barrs^; C. Ward. The Overall Haemostasis Potential; a Novel, Cost Effective, Global Coagulation Assay for Use in Canine Plasma. [Abstract] ACVIM 2012
• A. Dengate; M.C. Morel-Kopp; J. Braddock; R. Churcher; J. Beatty; V. Barrs; C. Ward^.  Delayed Fibrinolysis in Dogs with Naturally Occurring Pituitary Dependent Hyperadrenocorticism. [Abstract] ACVIM 2012
• Braddock JA, Hoffmann KL, Malik R. Exophthalmos in a Young French Bulldog. Aust Vet Pract 2007;37:159-164
• S Tasker, J A Braddock, R Baral, C R Helps, M J Day, T J Gruffydd-Jones, R Malik
• Diagnosis of feline haemoplasma infection in Australian cats using a real-time PCR assay. JFMS 2004;6:345-354
• Braddock JA, Tasker S, & Malik R. The use of real-time PCR in the diagnosis and monitoring of Mycoplasma haemofelis copy number in a naturally infected cat. JFMS 2004;6:161-165
• Braddock JA, Church DB, Robertson ID & Watson ADJ. Inefficacy of selegiline in treatment of canine pituitary-dependent hyperadrenocorticism. AVJ 2004;82:272-277
• Braddock JA, Tisdall PLC, Martin P & Malik R. Streptococcal spinal epidural empyema in a dog. Aust Vet Practit 2004;34:16-22
• Foster SF, Martin P, Braddock JA & Malik R. A retrospective analysis of feline bronchoalveolar lavage cytology and microbiology (1995-2000). JFMS 2004;6:189-198
• Broome CJ, Walsh VP & Braddock JA. Congenital portosystemic shunts in dogs and cats. NZ Vet J 2004;52:154-162
• Tasker S, Braddock JA, Baral R, Helps CR, Day MJ, Gruffydd-Jones TJ & Malik R. Diagnosis of feline haemoplasma infection in Australian cats using a real-time PCR assay JFMS 2004;6:345-354
• Braddock JA. Viewpoints: Diagnosis of Hyperadrenocorticism in the Dog. Aust Vet J 2003;1: 25-27
• Braddock, JA. Viewpoints: Medical Treatment of Hyperadrenocorticism in the Dog. Aust Vet J 2003;1:31-33
• Braddock JA, Church DB, Robertson ID & Watson ADJ. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. AVJ 2003;81:600-607
• Braddock JA, Church DB & Watson ADJ. Trilostane and selegiline evaluated for management of pituitary-dependent hyperadrenocorticism in dogs [abstract]. Scientific Proceedings BSAVA 45^th Annual Congress 2002: 587.
• Liptak J.M.; Hunt G.B.; Church D.B.; Malik R.; Braddock J.A.; Foster S.F.; Barrs V.R.; Swinney G.R.; Peaston A.E.; Court E.. Neoplastic Diseases of the Cranial and Caudal Vena Cavae: A Retrospective Review of Nine Cases and Surgical Considerations. [Abstract] VCS 2000
• Braddock JA & Foster SF. Trilostane Use for the Long-term Management of Hyperadrenocorticism Due to Adrenal Tumour in a Dog [in preparation].

Research

• 1999 – 2003: Prospective clinical drug trial at the University Veterinary Teaching Hospital Sydney, investigating the efficacy of two alternative medical treatments – trilostane and selegiline – for the management of hyperadrenocorticism in the dog. Long-term follow-up studies continue to date.

Masters Thesis

• Braddock JA: Investigation of some alternative therapies for management of pituitary-dependent hyperadrenocorticism in the dog. Master’s Thesis, Sydney, Australia, 2002, University of Sydney.